Financial

U.S. Ambulatory Surgery Center Market Reaches $49.19 Billion in 2026 as Outpatient Procedure Migration, Higher-Acuity Cases and ASC Consolidation Reshape U.S. Surgical Care

October 8, 2026

Ottawa, Oct. 08, 2026 (GLOBE NEWSWIRE) –

The U.S. ambulatory surgery center (ASC) market is gaining momentum as healthcare systems, physicians, payers, and investors increasingly shift eligible surgical procedures from hospital settings to cost-efficient outpatient facilities. According to Precedence Research, the U.S. ASC market is valued at USD 49.19 billion in 2026 and is expected to reach USD 84.17 billion by 2035, registering a 6.15% CAGR between 2026 and 2035.

The opportunity extends beyond overall revenue growth. The U.S. has approximately 6,000-6,600 Medicare-certified ASCs, while only about one-third of freestanding centers are affiliated with larger multi-site operators. The resulting fragmentation creates substantial opportunities for acquisitions, joint ventures, de novo development, physician partnerships, technology deployment and market expansion.

Fill out the form for samples, case studies, and examples: https://www.precedenceresearch.com/sample/8764

Market Data Snapshot

Metric	2026 Data / Outlook	Business Implication
U.S. ASC market size	USD 49.19 billion	Large addressable market for operators, suppliers, technology providers and investors
Forecast market size	USD 84.17 billion by 2035	Indicates substantial long-term expansion opportunity
CAGR, 2026-2035	6.15%	Supports continued capacity, technology and geographic investment
Medicare-certified ASCs	6,000-6,600	Highly fragmented facility base creates consolidation opportunities
Five largest multi-site operators	22% of centers	Significant market remains outside large national platforms
Largest operator share	8% of centers	No single operator dominates the facility landscape
Market growth scenarios	3.5%-7%	Procedure migration, utilization and capacity determine upside
Major specialty pools	12 categories	Multiple pathways for specialty-focused expansion

The underlying growth equation is increasingly influenced by procedure migration, case acuity, utilization, reimbursement, facility capacity and revenue per case, rather than center count alone. Precedence Research identifies orthopedics, ophthalmology, gastroenterology, pain management, ENT, urology and other procedural specialties as important components of the addressable ASC opportunity.

What the Latest Data Shows

The ASC market is evolving from a predominantly low-acuity outpatient model toward a broader platform capable of handling increasingly complex procedures. Advances in minimally invasive techniques, anesthesia, perioperative protocols, imaging and recovery management are expanding the range of procedures that can be performed without an overnight hospital stay.

Three structural forces are particularly important:

Site-of-care migration: More clinically appropriate procedures are moving from hospitals and hospital outpatient departments into ASCs.
Payer economics: Lower-cost outpatient settings create incentives to direct suitable procedures away from higher-cost hospital environments.
Physician alignment: Physician ownership, partnerships and joint ventures can influence case volume, facility utilization and investment decisions.

The economics are also becoming more dependent on higher-value procedures. Precedence Research notes that a leading national ASC operator recorded 3.5% same-facility case growth and 1.5% revenue-per-case growth in 2025, illustrating how procedure volume and case value can jointly influence revenue expansion.

Key Market Trends and Developments

Higher-Acuity Procedures Are Expanding the Addressable Market

Orthopedics is becoming particularly important as procedures historically concentrated in hospital settings increasingly become suitable for outpatient environments. Cardiovascular and spine procedures also represent areas where technology, patient selection and clinical protocols can expand ASC eligibility.

The market’s specialty mix includes:

Orthopedics
Ophthalmology
Gastroenterology
Pain management
ENT
General surgery
Urology
Gynecology
Cardiovascular procedures
Spine
Podiatry
Other specialties

For ASC operators, the strategic question is therefore shifting from “How many centers can we operate?” to “Which procedures, physicians and markets generate the strongest facility economics?”

Consolidation Is Accelerating

The fragmented market structure provides a significant pipeline for acquisitions, affiliations and joint ventures. Large operators are combining national scale with physician relationships and specialty expertise, while independent centers remain important targets for strategic expansion.

A major 2026 transaction illustrates the scale of consolidation: Ascension completed its acquisition of AMSURG, bringing more than 250 ambulatory surgery centers across 34 states into its national network.

The transaction also demonstrates why facility-level intelligence matters. The competitive value of an ASC depends on its location, specialty mix, physician relationships, procedure volumes, payer exposure and local competitive density—not simply the number of facilities acquired.

Capacity and Physician Recruitment Are Strategic Variables

Surgery Partners reported 157 ASCs and 19 surgical hospitals across 30 states at the end of 2025. Its 2025 revenue increased 6.2% to $3.31 billion, while same-facility revenue increased 4.9%, same-facility cases increased 3.4%, and revenue per case increased 1.4%. The company also recruited nearly 700 physicians and invested more than $180 million in acquisitions, robotic technology and de novo development.

These figures highlight a broader market trend: facility expansion, physician recruitment, technology investment and higher-acuity procedure growth are increasingly interconnected.

Regulatory and Reimbursement Intelligence Is Becoming More Important

For calendar year 2026, the ASC payment-rate update was finalized at 2.6% for ASCs meeting applicable quality-reporting requirements. The 2026 payment framework also includes changes involving ASC quality reporting and other outpatient payment policies.

For operators and investors, reimbursement intelligence needs to be evaluated alongside procedure migration, payer mix, local contracting, utilization and facility-level economics.

Buy the Report: https://www.precedenceresearch.com/checkout/8764

Segment and Regional Intelligence

Segment	Current Position	Growth Signal	Business Opportunity
Orthopedics	Major high-value procedure pool	Higher-acuity procedures expanding	Joint replacement, spine, musculoskeletal services and specialized facilities
Ophthalmology	Established ASC specialty	High procedure volume	Specialty centers, equipment and technology
Gastroenterology	Large established outpatient pool	Continued specialty-network expansion	GI-focused centers, equipment and physician partnerships
Pain Management	Established outpatient specialty	Continued demand	Specialty facilities and physician alignment
Cardiovascular	Emerging higher-acuity opportunity	Procedure eligibility expanding	Advanced technology, facility development and clinical capabilities
ENT	Established ASC specialty	Continued outpatient suitability	Specialty expansion and network development

Region	Market Consideration	Opportunity
South	Large healthcare footprint and substantial ASC activity	Network expansion, acquisitions and physician partnerships
West	Population growth and metropolitan demand	De novo centers and specialty expansion
Midwest	Diverse regional markets	Independent-center acquisition and affiliation
Northeast	Dense healthcare infrastructure	Specialty and hospital-to-ASC migration opportunities

Precedence Research identifies state and metropolitan-level analysis as particularly important because ASC economics vary substantially according to population growth, procedure demand, reimbursement, ASC penetration, hospital competition and migration potential.

Company and Competitive Intelligence

The competitive landscape includes national operators, hospital systems, physician-led platforms, specialty networks and regional ASC groups.

Company / Platform	Recent Development or Position	Strategic Significance
United Surgical Partners International	National-scale ASC platform	Scale, joint ventures and multispecialty expansion
SCA Health	National physician-partnership model	Physician alignment and network development
AMSURG	Expanded through major network combination and additional center acquisitions	Specialty scale and consolidation
HCA Healthcare	Operated 121 freestanding ASCs at year-end 2025	Integrated hospital-to-outpatient network
Surgery Partners	157 ASCs across 30 states at year-end 2025	Physician partnerships, acquisitions and higher-acuity growth
Regional physician-owned ASCs	Large fragmented market	Acquisition, affiliation and partnership pipeline

HCA Healthcare reported 121 freestanding ASCs and 31 freestanding endoscopy centers at December 31, 2025, reinforcing the importance of integrated outpatient networks within large healthcare systems.

AMSURG also expanded its portfolio in July 2026 through the acquisition of five North Carolina centers, demonstrating continued activity at the regional level alongside larger national consolidation.

Where the Market Opportunity Is Emerging

The data points toward several high-value opportunity areas:

1. Independent ASC consolidation
With only about one-third of freestanding ASCs connected to large multi-site operators, thousands of centers remain potential targets for acquisition, affiliation or joint-venture strategies.

2. Hospital-to-ASC migration
Procedures becoming clinically and economically suitable for outpatient treatment can create new demand for ASC capacity, equipment, staffing and technology.

3. Higher-acuity outpatient care
Orthopedic, cardiovascular and spine procedures can expand the revenue pool where clinical capability, reimbursement and infrastructure support migration.

4. Physician partnership models
Recruitment and alignment remain critical because physician relationships directly influence procedure volume and facility utilization.

5. Technology investment
Robotic surgery, advanced imaging, digital scheduling, patient-management platforms, monitoring technologies and advanced anesthesia systems are becoming increasingly relevant to ASC competitiveness.

How Precedence Research Helps Companies in the U.S. ASC Market

Precedence Research converts market developments into structured intelligence that can support expansion, competitive strategy, investment, sourcing, sales and business development decisions.

Precedence Research Solution	What the Client Gets	How It Helps in the U.S. ASC Market
Master Dataset	Companies, ASC facilities, specialties, procedures, ownership, locations, physicians, technologies, investments and expansion activity	Identify acquisition targets, white-space markets, prospects, partners and expansion opportunities
Precedence Quadrant	Competitive benchmarking across scale, capabilities, positioning, specialty exposure and strategic strength	Compare ASC operators, identify competitive gaps and assess positioning
Interactive Dashboard	Dynamic monitoring of companies, segments, regions, competitors, investments and market indicators	Track market changes without relying exclusively on static reports
Quality & Manufacturing Intelligence	Facility, capacity, technology, supplier, operational and development intelligence where applicable	Support equipment suppliers, technology companies, procurement and operational planning
Customized Research	Market-entry studies, customer intelligence, competitor research, opportunity mapping, pricing, demand and investment analysis	Answer specific expansion, GTM, M&A, investment and strategic questions

Master Dataset

For the ASC market, a market-specific dataset can map ASC operators, individual facilities, specialties, procedure exposure, ownership models, geographic presence, physician relationships, technology adoption, investments, acquisitions, partnerships and expansion plans.

Healthcare companies and suppliers can use this intelligence to identify target facilities, prioritize accounts, map competitive presence, identify underserved markets and build territory-level sales strategies.

Precedence Quadrant

Competitive benchmarking can evaluate operators according to facility scale, geographic footprint, specialty exposure, physician relationships, procedure capabilities, technology adoption, expansion activity and strategic positioning.

This enables decision-makers to distinguish between companies with large networks and companies generating strong facility-level or specialty-specific advantages.

Interactive Dashboard

Decision-makers can monitor changes across:

ASC operators and facility networks
Specialty and procedure trends
State and metropolitan markets
Competitor expansion
Acquisitions and joint ventures
Technology deployment
Physician partnerships
Investment activity
Market and demand indicators

This creates an ongoing intelligence layer for strategy, sales, business development and executive decision-making.

Quality & Manufacturing Intelligence

For ASC equipment, medical-device and healthcare-technology companies, intelligence can be structured around facility locations, installed capabilities, procedure requirements, technology adoption, capacity expansion, procurement signals, suppliers and operational developments.

This can help manufacturers identify where new ASC capacity is being developed, determine which facilities are potential customers, prioritize high-growth specialties and align product portfolios with evolving procedural requirements.

Customized Research

Precedence Research can develop market-specific studies covering:

ASC market-entry strategy
State and metropolitan opportunity assessment
Customer and buyer intelligence
Competitive intelligence
ASC company profiling
Facility-level opportunity mapping
Procedure and specialty intelligence
Technology adoption assessment
Demand analysis
Pricing and reimbursement analysis
Supplier intelligence
M&A target identification
Strategic benchmarking
Investment opportunity assessment
GTM strategy

Continuously Updated Market Intelligence

ASC market intelligence can be maintained according to the client’s operating requirements through monthly, quarterly, six-monthly or annual updates.

Monthly updates can support companies tracking acquisitions, facility openings, partnerships, product launches, major investments and competitor activity.

Quarterly intelligence can support commercial and strategy teams monitoring procedure trends, network expansion, physician recruitment, technology adoption and competitive positioning.

Six-monthly updates can provide a broader review of market structure, regional opportunity, capacity development and strategic shifts.

Annual updates can refresh market forecasts, competitive landscapes, segment opportunities, reimbursement developments and long-term investment priorities.

The objective is to ensure that companies are not making strategic decisions using outdated facility, competitor, technology or market information.

Conclusion

The U.S. ASC market is moving into a period where scale, procedure migration, physician alignment, facility productivity, technology adoption and local-market economics will increasingly determine competitive success. With a USD 49.19 billion market in 2026, a projected 6.15% CAGR, approximately 6,000-6,600 Medicare-certified ASCs, and a highly fragmented ownership structure, the market offers opportunities across operations, healthcare delivery, medical technology, investment, acquisitions and business development.

For companies competing in or supplying the ASC ecosystem, the key requirement is increasingly granular intelligence: which facilities are expanding, which procedures are migrating, which operators are acquiring, where capacity is being added, which technologies are being adopted, and which markets offer the strongest commercial potential.

Precedence Research provides the market data, competitive intelligence, facility-level analysis and customized research required to turn these developments into actionable business decisions.

Source: https://www.precedenceresearch.com/us-ambulatory-surgery-center-market

Related Reports